Major job opportunity: Director, BARDA Division of Research, Innovation, and Ventures (DRIVe). Deadline 7 Dec 2019

Dear All: BARDA’s Division for Research, Innovation and Ventures (DRIVe) was established earlier this year with a mission to develop countermeasures to protect Americans from natural and intentional health security threats. 

BARDA now seeks a permanent director for the Division. The job description for this role is that the Director will:

  • Use vision and strategic and scientific leadership to create programs that transform medical countermeasures and how they are made and used.
  • Pursue imaginative and innovative research and development projects with the potential to have a significant positive impact on national health care challenges and meet live-saving national security needs.
  • Identify promising MCMs and technology investment priorities and advance research and development strategies through public and private partnerships and collaborations with governmental and non-governmental organizations and other funding partners.
  • Communicate programmatic priorities, funding opportunities and models, and business practices to diverse audiences that include industry, governmental and non-governmental organizations, funding partners, and the general public.
  • Identify new business practices and funding mechanisms to increase efficiency and effectiveness in meeting programmatic objectives.
  • Organize, direct, and manage all human, financial, and informational resources to implement a comprehensive strategy that delivers effective high quality programs.

Could this be you? The deadline for applications (https://www.usajobs.gov/GetJob/ViewDetails/515065900) is 7 Dec 2019.

All best wishes, –jr

John H. Rex, MD | Chief Medical Officer, F2G Ltd. | Expert-in-Residence, Wellcome Trust. Follow me on Twitter: @JohnRex_NewAbx. See past newsletters and subscribe for the future: http://amr.solutions/blog/

Upcoming meetings of interest to the AMR community:

  • 29-30 Nov 2018 (Birmingham, UK): BSAC (British Society Antimicrobial Chemotherapy): Antibiotic Resistance Mechanisms Workshop for Researchers
  • 7 Dec 2018 (Boston, MA): BAARN, Boston Area Antimicrobial Resistance Network 2018 symposium, 8:30am to 7pm at The Starr Center (185 Cambridge Street, Boston, MA). This is an excellent networking opportunity, especially for those based in the Boston area. Register here.
  • [NEW] 17 Dec 2018 (online): Webinar on TDM of antibiotics, sponsored by the journal Clinical Mass Spectroscopy.
  • [NEW] 13 Dec 2018 (online): CDD webinar entitled “New Strategies in Antibiotic Drug Development.” Register here.
  • 15 Jan 2018 (London): BSAC’s Antimicrobial Chemotherapy Conference 2019: “An ABC for everyone involved in developing new antimicrobials.” Details here.
  • [NEW] 4-5 Feb 2019 (London): Hamied Foundation UK-India Antimicrobial Resistance Meeting 2019. This is a 2-day meeting focused on building research links between the UK and India with the specific aim of jointly addressing the challenge of AMR. Register here.
  • 14-15 Mar 2019 (Berlin): BEAM-, CARB-X-, and ND4BB-ENABLE-sponsored Berlin Conference on Novel Antimicrobials and AMR Diagnostics. Details here.
  • 21-22 Mar 2019 (Birmingham, UK): BSAC Spring Conference.
  • [NEW] 26 Mar 2019 (London, UK): Sponsored by The Economist, a 1-day symposium entitled “Antimicrobial Resistance: Preventing an antibiotic apocalypse.” Register here.
  • [NEW] 13-16 Apr 2019 (Amsterdam): Annual ECCMID meeting.
  • [NEW] 24-26 Apr 2019 (Boston). Annual SHEA (Soc. for Hospital Epidemiology of America) Spring meeting
  • [NEW] 3-6 Jun 2019 (Philadelphia): Annual BIO meeting
  • [NEW] 20-24 June 2019 (San Francisco): Annual ASM Microbe meeting.
  • [NEW — mark your calendar now!] 3-6 Sep 2019 (Boston). Annual ASM-ESCMID Conference on Antibiotic Development. The Bootcamp series will continue on 3 Sep with the main meeting on 4-6 Sep. Mark your calendar now and check back here for details.
  • [NEW] 6-8 Sep 2019 (Bilbao, Spain): 5th ESCMID conference on Vaccines. Check back here for details.
  • [NEW] 2-6 Oct 2018 (Washington, DC): IDSA’s annual IDWeek meeting.
  • 19-27 Oct 2019 (Annecy, France): International Course on Antibiotics and Resistance (ICARe) – A soup-to-nuts intensive residential training program on all things AMR, especially R&D for new antibiotics. See this link for details.

Share

Leaky pipe(line)s, Part 2 / CARB-X reboot / WHO 2021 pipeline review

Dear All, We have a 3-part discussion today on the theme of “I want a new drug … so how do I find it?” Off we go! First, the 14 June 2022 newsletter entitled “Leaky Pipe(lines) / When Is A Molecule A Drug” generated further discussions that are worth sharing: It was noted the microdosing

Antibiotic procurement models for LMICs / G7 Leaders call for Pull!

Dear All, Two stops on our tour today: (i) an excellent survey of incentive models and (ii) a final communique from the recent G7 meetings. First up, CGD (Center for Global Development) have released a report (link) entitled “Leveraging Purchasing Systems to Ensure Access, Stewardship, and Innovation: A Landscape Review of Current and Potential Market Structures

Leaky pipe(lines) / When is a molecule a drug? (Part 1 of 2)

Dear All, I was fascinated by this recent paper in AAC: Neha K. Prasad, Ian B. Seiple, Ryan T. Cirz, and Oren S. Rosenberg. Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020. Antimicrob Agents Chemother. 2022 May 17;66(5):e0005422. doi:10.1128/aac.00054-22. (Addendum: This newsletter has a follow-up newsletter.) In brief,

FDA/CVM: Antimicrobial use in companion animals

Dear All, Post-newsletter addendum: I’ve learned that USDA will host a 10 Aug 2022 (virtual, 10a-4.30p ET) workshop on AMR in food agriculture. See the meetings calendar for more details; go here to register. I’ll confess to having missed entirely the request back in February 2022 from FDA’s Center for Veterinary Medicine (CVM) for comments on antimicrobial

Scroll to Top